On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Sunday, September 27, 2009

Overtreated, excess care

›
"Overtreated", "Overdiagnosed", and "Overdosed",... these are the terms I have used in one of seminars several...
1 comment:
Monday, September 21, 2009

Reporting pregnancies during clinical trials

›
Unless a clinical trial is designed for the pregnancy women, the typical clinical trial will exclude the females with pregnancy and lactatin...
4 comments:
Friday, September 11, 2009

Conficence Interval vs. Credible Interval

›
I recently participated in a project to compare two different ways to do the meta analysis: the traditional way to pool the database directl...
5 comments:
Friday, September 04, 2009

Placebo and Sham treatment: are they really inactive?

›
According the ICH guidance E10 (CHOICE OF CONTROL GROUP AND RELATED ISSUES IN CLINICAL TRIALS), "A placebo is a "dummy" trea...
Sunday, August 30, 2009

SAS IQ and OQ

›
I am not sure how many people really know these abbreviations: DOE, IQ, OQ, PQ, PV. These are the terms used in the validation of a software...
4 comments:
Sunday, August 23, 2009

Hochberg procedure for adjustment for multiplicity - an illustration

›
In a May article, I discussed several practical procedures for multiple testing issue . One of the procedures is Hockberg's procedure. T...
5 comments:
Saturday, August 08, 2009

Poisson regression and zero-inflated Poisson regression

›
Poisson regression is a method to model the frequency of event counts or the event rate, such as the number of adverse events of a certain t...
2 comments:
Saturday, August 01, 2009

Epidemiology terms, but used in clinical trials

›
Some terms often used in epidemiology fields are actually pretty commonly used in clinical trials. At least for me, I first learned these te...
1 comment:
Tuesday, July 21, 2009

Some axiom quotes about statistics

›
I had a chance to listen to a seminar by Richard De Veaux in an event organized by SAS JMP for data mining. Dick is really an excellent sp...
Thursday, July 16, 2009

Dose Escalation and Modified Fabonacci Series

›
Dose-escalation is a type of clinical trial design in which the amount of the drug is increased with each cohort that is added. Each cohort ...
Saturday, July 11, 2009

Odds Ratio and Relative Risk

›
Odds Ratio (OR) and Relative Risk (RR) are two ratios often used in the epidemiology studies and the clinical trials. They are related, but ...
Sunday, July 05, 2009

The interactive voice response system

›
Interactive Voice Response (IVR) is an interactive technology that allows a computer to detect voice and keypad inputs. Its use in clinical...
5 comments:
Saturday, June 27, 2009

Spaghetti Plot

›
The first time when I used the term "Spaghetti" was for one of the pharmacokinetic studies where I would like to see the time-conc...
3 comments:
Saturday, June 20, 2009

Williams Design

›
Williams Design is a special case of orthogonal latin squares design. It is a high-crossover design and typically used in Phase I studies. D...
5 comments:

Protocol Amendment after IND

›
In clinical development, filing of IND (Investigational New Drug) is an important milestone. FDA is required by the Modernization Act to res...
Friday, June 12, 2009

Double Dummy Technique

›
Double dummy is a technique for retaining the blind when administering supplies in a clinical trial, when the two treatments cannot be made ...
15 comments:
Friday, June 05, 2009

Group t-test or Chi-square test based on the summary data

›
Sometimes, the only data we have is the summary data (mean, standard deviation, # of subjects). Can we use the summary data (instead of the ...
Saturday, May 30, 2009

Pharmacokinetics: Verify the Steady State Under Multiple Doses

›
For a multiple-dose regimen, the amount of drug in the body is said to have reached a steady state level if the amount or average concentrat...
Saturday, May 23, 2009

Statistical validation of the surrogate endpoints

›
A surrogate endpoint is intended to substitute for a clinical endpoint. A surrogate endpoint is expected to predict clinical benefit (or ha...
1 comment:
Friday, May 15, 2009

Imaging analysis in clinical trial

›
Medical imaging has now been a critical part in clinical trials. It can be used in many aspects of clinical trial process: 1) Disease dia...
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.